Publicaciones en las que colabora con José María Pelayo Terán (17)

2024

  1. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

2023

  1. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study

    Epidemiology and psychiatric sciences, Vol. 32, pp. e50

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  2. Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey

    Epidemiology and Psychiatric Sciences, Vol. 31

2021

  1. Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105

  2. Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak

    Depression and Anxiety, Vol. 38, Núm. 5, pp. 528-544

  3. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic

    Epidemiology and Psychiatric Sciences, Vol. 30

2011

  1. Insight dimensions in first-episode psychosis patients: Clinical, cognitive, pre-morbid and socio-demographic correlates

    Early Intervention in Psychiatry, Vol. 5, Núm. 2, pp. 140-149

2008

  1. 1-year follow-up study of cognitive function in first-episode non-affective psychosis

    Schizophrenia Research, Vol. 104, Núm. 1-3, pp. 165-174

  2. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis

    Psychological Medicine, Vol. 38, Núm. 9, pp. 1257-1266

  3. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 8, pp. 1936-1943

  4. Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: Insights from the Clinical Programme on Early Phases of Psychosis

    Early Intervention in Psychiatry, Vol. 2, Núm. 3, pp. 178-187

  5. Lack of association between clinical and cognitive change in first-episode psychosis: The first 6 weeks of treatment

    Canadian Journal of Psychiatry, Vol. 53, Núm. 12, pp. 839-847

  6. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis

    Schizophrenia Research, Vol. 102, Núm. 1-3, pp. 206-209

  7. Pretreatment predictors of cognitive deficits in early psychosis

    Psychological Medicine, Vol. 38, Núm. 5, pp. 737-746

2007

  1. Cognitive dimensions in first-episode schizophrenia spectrum disorders

    Journal of Psychiatric Research, Vol. 41, Núm. 11, pp. 968-977

  2. Neuropsychological functioning and brain structure in schizophrenia

    International Review of Psychiatry, Vol. 19, Núm. 4, pp. 325-336